Provided by Tiger Trade Technology Pte. Ltd.

NovoCure

13.67
-0.0800-0.58%
Post-market: 13.59-0.0800-0.59%19:10 EST
Volume:2.58M
Turnover:35.53M
Market Cap:1.56B
PE:-8.50
High:14.38
Open:13.55
Low:13.26
Close:13.75
52wk High:21.55
52wk Low:9.82
Shares:114.00M
Float Shares:94.15M
Volume Ratio:0.69
T/O Rate:2.74%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.6074
EPS(LYR):-1.5638
ROE:-38.89%
ROA:-9.40%
PB:4.58
PE(LYR):-8.74

Loading ...

Novocure to Participate in Leerink Global Healthcare Conference

Reuters
·
Yesterday

Novocure Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
Feb 27

Novocure Ltd reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
Feb 26

Stock Track | NovoCure Plunges 7.4% Pre-Market on Margin Pressure and Weak EBITDA Outlook

Stock Track
·
Feb 26

Earnings Flash (NVCR) Novocure Reports Q4 Loss $0.22 a Share, vs. FactSet Est of $0.41 Loss

MT Newswires Live
·
Feb 26

Novocure Q4 revenue slightly beats expectations, margins drop

Reuters
·
Feb 26

Novocure Q4 Revenue USD 174.35 Million Vs. IBES Estimate USD 173.4 Million

Reuters
·
Feb 26

Novocure Q4 net loss hits USD 24.5 million as R&D spending rises 19% to USD 60.9 million

Reuters
·
Feb 26

Novocure Q4 Pretax Profit USD -40.954 Million

THOMSON REUTERS
·
Feb 26

Novocure Ltd: Outlook 2026 Adj Ebitda $-20 Mln - $0 Mln

THOMSON REUTERS
·
Feb 26

Novocure Ltd - 2026 Revenue Guidance $675 Mln-$705 Mln

THOMSON REUTERS
·
Feb 26

Today’s Market Recap: AI Momentum Lifts U.S. Markets as Tariff Battles and Global Trade Tensions Unfold

TradingKey
·
Feb 26

NovoCure Up Over 27%, On Pace for Largest Percent Increase Since December 2024 -- Data Talk

Dow Jones
·
Feb 26

Novocure jumps 11% after CMS reinstates Medicare billing privileges

TIPRANKS
·
Feb 25

Novocure Ltd - CMS Reinstates Medicare Billing Privileges Retroactively - SEC Filing

THOMSON REUTERS
·
Feb 25

Novocure Ltd - Company Expects No Revenue Impact From Ineligibility Period - SEC Filing

THOMSON REUTERS
·
Feb 25

Novocure Inc. regains Medicare billing privileges after CMS rescinds revocation

Reuters
·
Feb 25

Earning Preview: NovoCure Q4 revenue is expected to increase by 9.85%, and institutional views are balanced-to-cautious

Earnings Agent
·
Feb 19

Sector Update: Health Care Stocks Higher Thursday Afternoon

MT Newswires Live
·
Feb 13

NovoCure Up Over 26%, on Pace for Largest Percent Increase Since December 2024 -- Data Talk

Dow Jones
·
Feb 13